Health In Tech (HIT) vs Roadzen (RDZN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Roadzen (RDZN) has outperformed Health In Tech (HIT) over the past year, losing 36.9% versus a loss of 72.5%. Roadzen is the larger company by market cap ($81.0 million vs $30.5 million), about 2.7 times the size, while Health In Tech is growing revenue faster (+71.0% vs +24.2%). Health In Tech converts more of its revenue into profit, with a net margin of 3.8% versus -40.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HIT | RDZN |
|---|---|---|
| Share price | $0.3827 | $0.9401 |
| Market cap | $30.50M | $80.96M |
| 1-day change | +12.36% | -1.74% |
| YTD return | -75.93% | -60.99% |
| 1-year return | -72.47% | -36.91% |
| P/E ratio (TTM) | — | 4.70 |
| Forward P/E | — | 8.55 |
| EPS (TTM) | $-0.19 | $0.20 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $33.33M | $55.02M |
| Revenue growth (YoY) | +70.99% | +24.21% |
| Net income (latest FY) | $1.28M | $-22.52M |
| Gross margin | 62.82% | 61.33% |
| Operating margin | — | -25.44% |
| Net margin | 3.84% | -40.92% |
| 52-week high | $2.10 | $2.56 |
| 52-week low | $0.30 | $0.855 |
| Distance from 52-week high | -81.78% | -63.28% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +715.26% | +431.86% |
| Average volume | 177.83K | 350.46K |
| Shares outstanding | 67.09M | 86.12M |
| Employees | 87 | 458 |
| Sector | Finance | Finance |
| Industry | Specialty Insurers | Specialty Insurers |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Roadzen is about 2.7 times larger than Health In Tech by market value ($80.96M vs $30.50M).
- RDZN has outperformed HIT by 35.6 percentage points over the past year.
- Health In Tech is more profitable, keeping 3.8 cents of every revenue dollar as net income versus -40.9 cents for Roadzen.
- Health In Tech grew revenue faster in its latest fiscal year (+70.99% vs +24.21%).
About Health In Tech
HIT stock →Health In Tech, Inc. operates as an insurance technology platform company in the United States.
Finance · Specialty Insurers · 87 employees
About Roadzen
RDZN stock →Roadzen, Inc. operates an Insurtech company in India, the United States, the United Kingdom, and Europe.
Finance · Specialty Insurers · 458 employees
HIT vs RDZN FAQ
Which is bigger, Health In Tech or Roadzen?
Roadzen (RDZN) is larger, with a market capitalization of $80.96M compared with $30.50M for Health In Tech (HIT).
Which stock has performed better over the past year, HIT or RDZN?
RDZN returned -36.91% over the past 12 months, compared with -72.47% for HIT (price return, excluding dividends). Past performance does not predict future results.
Are Health In Tech and Roadzen in the same industry?
Yes. Both are classified in the Specialty Insurers industry within the Finance sector.